Anhui Anke Biotechnology

Anhui Anke Biotechnology is one of the...

• CSI 500.

Anhui Anke Biotechnology is a company listed under the stock ticker 300009 (CN).

View the org chart displaying its 14 main executives

Most searched biographies at Anhui Anke Biotechnology

• Jianping Yao, Chief Executive Officer
• Xiaoping Geng, Independent Director
• Liming Song, Vice Chairman of the Board

Create your alert
to follow the executive moves at Anhui Anke Biotechnology.

Anhui Anke Biotechnology has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Anhui Anke Biotechnology

Social media about Anhui Anke Biotechnology

• Anhui Anke Biotechnology on Wikipedia, Google News & Yahoo Finance
• Anhui Anke Biotechnology on LinkedIn, Twitter & YouTube

Contact by email its executives including Jianping Yao

Call Anhui Anke Biotechnology at +86 999...

View the org chart

Register to receive your alert

Report an error